Project Grant RF1AG099026
- Federal Project Grant Award Summary Duke University's Office of Research Administration was awarded $509,413 by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) on September 15, 2025, for a project period extending through May 31, 2030. The award supports scientific research investigating epitranscriptomic regulation of microglia in Alzheimer's disease (AD), specifically examining how m6A (N6-methyladenosine) modifications of messenger RNA control microglial...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the University of Michigan a $303,449 project grant effective June 1, 2025, through May 31, 2027, under the Aging Research program (CFDA 93.866) to investigate the genomic impact of transposable elements (TEs) in Alzheimer's disease and related dementias (ADRD). The research will leverage large-scale genomic datasets and clinical information from major Alzheimer's disease cohorts to overcome analytical challenges...
- Federal Project Grant Award Summary The University of South Florida received a $1.70 million project grant awarded September 22, 2025, by the National Institute on Aging under the Aging Research program (CFDA 93.866) to conduct transcriptome-wide mapping of the brain M6A methylome in Alzheimer's disease. The award, extending through May 31, 2030, supports comprehensive research utilizing novel technologies for N6-methyladenosine (M6A) profiling at base-resolution to create the first...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $493,972 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective January 1, 2026 through December 31, 2030. This award funds research on cell type-specific epitranscriptomic regulation in the brain during aging and Alzheimer's disease (AD). The project investigates how adenosine methylation (M6A), the most abundant internal messenger RNA...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded $852,273 to The Trustees of Columbia University in the City of New York, Health Sciences Division, through the Aging Research program (CFDA 93.866) on September 1, 2025, for a project extending through May 31, 2030. This Project Grant funds a comprehensive genetic mapping study investigating the role of RNA modifications—specifically N6-methyladenosine (M6A) and pseudouridine (Ps)—in Alzheimer's disease (AD) pathogenesis...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $3.53 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) for the period September 1, 2025 through August 31, 2029. The award funds comprehensive genome-wide research to identify sex-specific genetic drivers of cerebrovascular disease (CVD) in the context of Alzheimer's disease (AD). The research team will conduct extensive statistical genetic analyses...
- Federal Project Grant Award Summary Emory University received a $528,876 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective June 1, 2025 through March 31, 2030. This award supports the development and application of novel analytical tools to investigate cis- and trans-genetic regulation of brain transcriptomics and proteomics associated with Alzheimer's disease and related dementias (AD/ADRD). The research extends current...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Johns Hopkins University $1.31 million under the Aging Research program (CFDA 93.866) to develop and apply statistical methodologies for improving scientific inferences in Alzheimer's Disease (AD) research. The project, initiated May 15, 2025, and scheduled for completion January 31, 2030, addresses critical analytical challenges in cross-sectional and longitudinal AD studies. The research team will deliver...
- Federal Project Grant Award Summary The University of Florida, Division of Sponsored Research, received a $507,371 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) effective June 1, 2025, through March 31, 2030. This award funds research investigating the roles of CASP8 SVA GGGAGA repeat expansions in Alzheimer's Disease (AD). The project will deliver scientific research products examining microsatellite repeat expansions as potential genetic...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded $127,224 to the University of California, San Diego on October 24, 2025, under the Aging Research program (CFDA 93.866) to support scientific investigation into the pathological mechanisms of Alzheimer's disease (AD). The project, which extends through August 31, 2028, will elucidate the role of s-nitrosylated phospholipase D3 (SNO-PLD3) in microglial and neuronal pathophysiology associated with AD. Specifically,...
The University of Miami's School of Medicine received a $3.23 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded March 1, 2026, with a completion date of February 28, 2031. This five-year research initiative will conduct integrative analyses focused on understanding the X chromosome's contribution to Alzheimer's disease (AD) risk and protection in large, heterogeneous population cohorts. The project addresses a significant gap in AD research by systematically investigating X chromosome genetics and epigenetics, which have been historically overlooked due to analytical complexity. The research will be executed through three primary aims: (1) expanding knowledge of X chromosome genetic architecture in relation to AD risk and protection; (2) identifying DNA methylation differences on the X chromosome associated with AD in both brain and blood tissues; and (3) performing integrative multi-omics analysis to decipher the functional basis of X chromosome variants associated with AD. By leveraging genetic, DNA methylation, and multi-omics population cohort datasets, the research will substantially improve understanding of X chromosome contributions to AD pathogenesis, thereby facilitating development of more targeted prevention, diagnostic, and therapeutic strategies for this age-related neurodegenerative disease.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $3.2m | 2/19/26 |